Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Sentante has received CE marking for its haptic endovascular robotic platform designed for remote vascular procedures. The system captures force, torque, and motion data from each procedure, laying the groundwork for future AI-supported endovascular interventions.
Cigna Healthcare announced an AI expansion to its personalized care management programs, aiming to identify health needs sooner and connect more customers with clinical support.
SimBioSys has partnered with Ferrum Health to make its FDA-cleared TumorSight Viz platform available through Ferrum's Model Hub, improving deployment and management of AI surgical planning capabilities across U.S. health systems.
Genesis Automation Healthcare will debut its unified platform and introduce the Agentic AI Design Partner Program at AHRMM26 in San Antonio, marking its first public appearance as a combined company.
An independent American Heart Association AI Impact Report found that Ultromics' EchoGo Heart Failure system could identify heart failure with preserved ejection fraction up to nine months earlier than standard care.
EBSCO Clinical Decisions has partnered exclusively with the International Home Care Nurses Organization to integrate validated clinical competencies into its Dynamic Health platform, providing home care professionals with evidence-based guidance for safer patient care.
The Digital Medicine Society (DiMe) has introduced a new initiative, 'Operationalizing AI Governance in Healthcare', to provide practical tools and templates for responsible AI deployment in healthcare systems, developed with Qualified Health as the title sponsor.
Karoo Health has secured $16.2 million in Series A funding, co-led by 7wire Ventures and Allumia Ventures, to expand its AI cardiovascular care platform and partnerships with health plans and cardiology providers.
Bristol Myers Squibb will deploy NVIDIA's DGX Vera Rubin NVL72 systems to enhance its AI capabilities across drug discovery and development, expanding its existing collaboration with the chipmaker to create the most powerful AI infrastructure in life sciences.
Haier Biomedical presented its digital blood management platform at the ISBT Congress 2026 in Kuala Lumpur, highlighting integrated solutions for blood collection, processing, storage, and clinical application using IoT and AI technologies.
Ping An Insurance showcased new AI-powered products at the World Artificial Intelligence Conference 2026, introducing healthcare, insurance, and financial technologies to enhance efficiency and accessibility.
Fuse Oncology has launched FuseRx, a prescribing and treatment-intent platform for radiation oncology, debuting at the 2026 AAPM Annual Meeting in Vancouver. The system integrates prescribing, simulation, and treatment planning into one guided workflow with built-in validation and pathway support.
An independent study by Stanford and Harvard researchers found that physicians chose OpenEvidence more frequently than ChatGPT, Claude, Gemini, and all other external AI chatbots combined when given unrestricted access to clinical tools.
Bluestaq has introduced BLUESTAQ / ARQ, a multi-environment data infrastructure platform built for secure and compliant data management across sectors including healthcare, finance, agriculture, and government.
MANE has obtained global rights to produce and commercialize Arzeda's ViaLeaf Reb M sweetener technology, expanding their sugar reduction partnership.
DarioHealth has been selected by a Fortune 50 employer to deliver its AI enhanced cardiometabolic care platform for over 100,000 employees. The program launches in Fall 2026 with revenue expected to begin by year end.
The Coalition for Health AI has launched PULSE, a national program to help public health agencies evaluate and implement generative AI. OpenAI and Anthropic are providing enterprise licenses, while Accenture will support with onboarding and best practice playbooks.
Sensi.AI has been named a preferred partner for SYNERGY HomeCare, bringing its care intelligence platform to more than 250 franchisees across 625 U.S. locations to improve senior care through proactive insights and automated workflows.
Raidium has launched its AI imaging platform, Raidium Read, at U.S. cancer centers. The tool, already in use at Moffitt Cancer Center, streamlines oncology imaging workflows by integrating lesion detection, segmentation, and tracking within a single interface.
MindWalk Holdings has been included in the Russell 3000E Index and will release its fourth quarter and full-year 2026 results on July 22.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
